China Resources Double-Crane Pharmaceutical Co., Ltd. held the 16th session of the sixth directorate meeting on June 9, 2014, which discussed and approved issues including the proposal of Zhang Wenzhou's resignation from the position of Independent Director, the proposal of recommendation of Wu Zhi'ang Independent Director and the proposal of adjusting members of Special Committees of Directorate.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.64 CNY | -1.41% | -7.44% | +16.34% |
11:01am | CR Double-Crane Pharmaceutical's Unit Gets Nod to Market Schizophrenia Drug | MT |
05-08 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Lidocaine Hydrochloride Injection | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.34% | 3.1B | |
+39.92% | 723B | |
+34.28% | 595B | |
-3.98% | 369B | |
+20.35% | 332B | |
+2.90% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.12% | 168B |
- Stock Market
- Equities
- 600062 Stock
- News China Resources Double-Crane Pharmaceutical Co.,Ltd.
- China Resources Double-Crane Pharmaceutical Co., Ltd. Announces Executive Changes